CAPTRUST Financial Advisors
KRSA

CAPTRUST Financial Advisors’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,090
Closed -$60.3K – 2650
2023
Q2 		$60.3K Hold
2,090
– – ﹤0.01% 2417
2023
Q1 		$127K Buy
+2,090
New +$26.4K ﹤0.01% 2129

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CAPTRUST Financial Advisors's KRSA Position: Q3 2023 in Review

CAPTRUST Financial Advisors sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2023, closing a stake of 2,090 shares — an estimated $60.3K sold.

CAPTRUST Financial Advisors first reported a position in KRSA in Q1 2023 and held it in 2 quarters. The position peaked at $127K in Q1 2023. 15 funds tracked by Wall St. Rank hold KRSA as of Q3 2023.

  • CAPTRUST Financial Advisors reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,090 Korsana Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $60.3K.
  • CAPTRUST Financial Advisors first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Korsana Biosciences, Inc. Common Stock position peaked at $127K in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.